Currently a member of Boehringer Ingelheim’s Business Development & Licensing Team, based in Germany, Julie is responsible for leading contract negotiations and managing strategic alliances that support the scientific and business development objectives of the Innovation Unit at Boehringer Ingelheim.
In her current role and throughout her career, Julie has proactively and effectively cooperated with key stakeholders in the life sciences ecosystem, from both the private and public sectors, driving the establishment of strategic alliances and partnerships to progress innovative science towards application.
Prior to joining Contracts and Alliance Management (CAM), Julie was the Head of Research Beyond Borders (RBB) Project Office and Strategic Partnering at Boehringer Ingelheim, where she fostered the development and implementation of new science project proposals and their enablement through external sources of innovation. Before the RBB, Julie was the Director of Corporate Development at Genome Canada, where she developed and lead strategic international partnerships with an emphasis on public-private partnerships.
Earlier in her career, Julie supported Boehringer’s Infectious Disease Research efforts at its Canadian research site, in her role as the Head of Scientific Administration and External Scientific Affairs. Also as a consultant, Julie has worked with inventors, academic institutions, start-up companies, investors and other stakeholders, as well as on strategic planning including business development and partnering initiatives, commercialization strategies, in addition to licensing and due diligence of new technologies with strong applied and commercial potential.